The Economist 20260620 Wrong prescription Summary
Generated by Codex with GPT-5
This summary covers The Economist’s June 20th, 2026 Leaders article listed in the contents under Chinese biotech and published under the headline Wrong prescription.
The article argues that America is in danger of mistaking medical innovation for another battlefield in its technology contest with China. Chinese biotechnology has moved from imitation to genuine discovery, and American drug companies are increasingly licensing Chinese-developed molecules. Some politicians now want to treat that trend as a national-security threat, extending investment restrictions to biotech deals and even asking the Food and Drug Administration to disregard Chinese clinical-trial data.
Continue ...